Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes

Abstract The targets for continuous glucose monitoring (CGM)-derived metrics were recently set; however, studies on CGM data over a long period with stable glycemic control are limited. We analyzed 194,279 CGM values obtained from 19 adult Japanese patients with type 1 diabetes. CGM data obtained du...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Hiroshi Ikegami
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b3dfa88e5d7f471cb6f63d00733e8478
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b3dfa88e5d7f471cb6f63d00733e8478
record_format dspace
spelling oai:doaj.org-article:b3dfa88e5d7f471cb6f63d00733e84782021-12-02T14:21:42ZRelationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes10.1038/s41598-021-83599-x2045-2322https://doaj.org/article/b3dfa88e5d7f471cb6f63d00733e84782021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83599-xhttps://doaj.org/toc/2045-2322Abstract The targets for continuous glucose monitoring (CGM)-derived metrics were recently set; however, studies on CGM data over a long period with stable glycemic control are limited. We analyzed 194,279 CGM values obtained from 19 adult Japanese patients with type 1 diabetes. CGM data obtained during stable glycemic control over four months were analyzed. CGM-related metrics of different durations “within 120, 90, 60, 30, and 7 days” were calculated from baseline. Time in range (TIR; glucose 70–180 mg/dL), time above range (TAR; glucose ≥ 181 mg/dL), and average glucose levels, but not time below range (TBR; glucose ≤ 69 mg/dL), strongly correlated with glycated hemoglobin (HbA1c) values (P < 0.0001). TBR correlated with glucose coefficient of variation (CV) (P < 0.01). Fasting serum C-peptide levels negatively correlated with glucose CV (P < 0.01). HbA1c of approximately 7% corresponded to TIR of 74% and TAR of 20%. The shorter the CGM period, the weaker was the relationship between HbA1c and CGM-related metrics. TIR, TAR, and average glucose levels accurately reflected HbA1c values in Japanese patients with type 1 diabetes with stable glycemic control. Glucose CV and TBR complemented the limitation of HbA1c to detect glucose variability and hypoglycemia. Stable glycemic control with minimal hypoglycemia depended on residual β-cell function.Naru BabayaShinsuke NosoYoshihisa HiromineYasunori TaketomoFumimaru NiwanoSawa YoshidaSara YasutakeYumiko KawabataHiroshi IkegamiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Naru Babaya
Shinsuke Noso
Yoshihisa Hiromine
Yasunori Taketomo
Fumimaru Niwano
Sawa Yoshida
Sara Yasutake
Yumiko Kawabata
Hiroshi Ikegami
Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
description Abstract The targets for continuous glucose monitoring (CGM)-derived metrics were recently set; however, studies on CGM data over a long period with stable glycemic control are limited. We analyzed 194,279 CGM values obtained from 19 adult Japanese patients with type 1 diabetes. CGM data obtained during stable glycemic control over four months were analyzed. CGM-related metrics of different durations “within 120, 90, 60, 30, and 7 days” were calculated from baseline. Time in range (TIR; glucose 70–180 mg/dL), time above range (TAR; glucose ≥ 181 mg/dL), and average glucose levels, but not time below range (TBR; glucose ≤ 69 mg/dL), strongly correlated with glycated hemoglobin (HbA1c) values (P < 0.0001). TBR correlated with glucose coefficient of variation (CV) (P < 0.01). Fasting serum C-peptide levels negatively correlated with glucose CV (P < 0.01). HbA1c of approximately 7% corresponded to TIR of 74% and TAR of 20%. The shorter the CGM period, the weaker was the relationship between HbA1c and CGM-related metrics. TIR, TAR, and average glucose levels accurately reflected HbA1c values in Japanese patients with type 1 diabetes with stable glycemic control. Glucose CV and TBR complemented the limitation of HbA1c to detect glucose variability and hypoglycemia. Stable glycemic control with minimal hypoglycemia depended on residual β-cell function.
format article
author Naru Babaya
Shinsuke Noso
Yoshihisa Hiromine
Yasunori Taketomo
Fumimaru Niwano
Sawa Yoshida
Sara Yasutake
Yumiko Kawabata
Hiroshi Ikegami
author_facet Naru Babaya
Shinsuke Noso
Yoshihisa Hiromine
Yasunori Taketomo
Fumimaru Niwano
Sawa Yoshida
Sara Yasutake
Yumiko Kawabata
Hiroshi Ikegami
author_sort Naru Babaya
title Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
title_short Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
title_full Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
title_fullStr Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
title_full_unstemmed Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
title_sort relationship of continuous glucose monitoring-related metrics with hba1c and residual β-cell function in japanese patients with type 1 diabetes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b3dfa88e5d7f471cb6f63d00733e8478
work_keys_str_mv AT narubabaya relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT shinsukenoso relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT yoshihisahiromine relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT yasunoritaketomo relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT fumimaruniwano relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT sawayoshida relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT sarayasutake relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT yumikokawabata relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
AT hiroshiikegami relationshipofcontinuousglucosemonitoringrelatedmetricswithhba1candresidualbcellfunctioninjapanesepatientswithtype1diabetes
_version_ 1718391511078404096